D6567
DRF 2519
≥98% (HPLC), solid
Synonym(s):
5-[[4-[2-(4-Oxo-2H-1,3-benzoxazin3(4H)-yl)ethoxy]phenyl]methyl2,4-thiazolidinedione
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
assay
≥98% (HPLC)
form
solid
storage condition
under inert gas
color
white
solubility
DMSO: ≥10 mg/mL
storage temp.
2-8°C
SMILES string
O=C1NC(=O)C(Cc2ccc(OCCN3COc4ccccc4C3=O)cc2)S1
Biochem/physiol Actions
DRF-2519 is a dual PPARα/γ activator. DRF-2519 has better reduction of plasma insulin, triglyceride, and free fatty acid levels than those treated with rosiglitazone.
Storage Class
13 - Non Combustible Solids
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service